Exact Mass: 635.6579949999999
Exact Mass Matches: 635.6579949999999
Found 116 metabolites which its exact mass value is equals to given mass value 635.6579949999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cer(d18:1/23:0)
Ceramides, also known as N-acylsphingosines, consist of a sphingoid base linked to a fatty acid chain via the amine group. Ceramides are one of the hydrolysis byproducts of sphingomyelin via the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase, E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis and many other tissues (PMID: 25935). They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key to the biosynthesis of glycosphingolipids and gangliosides. Cer(d18:1/23:0), in particular, consists of a monounsaturated 18-carbon dihydroxylated sphingoid base linked to one chain of tricosanoic acid. Cer(d18:1/23:0) has been identified in the stratum corneum by reversed-phase HPLC coupled with APPI–MS (PMID: 17027012). It has been found in human blood plasma by gas-liquid chromatography on high temperature polarizable capillary columns (PMID: 2755317, 8354950). Cer(d18:1/23:0) is an sphingolipid identified in stratum corneum by reversed-phase high-performance liquid chromatography photospray ionization mass spectrometry.
Cyanidin 3-O-(6'-dioxalyl-glucoside)
Cer[NS] d41:1
Found in mouse liver; TwoDicalId=43; MgfFile=160824_Liver_DHA_Neg_15; MgfId=1310 Found in mouse kidney; TwoDicalId=50; MgfFile=160827_Kidney_normal_Neg_02_never; MgfId=2081
(1R,2S,5R,6R,9R,10S)-rel-1,2,5,6,9,10-Hexabromocyclododecane
N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]tricosanamide
(Z)-N-[(2S)-1,3-dihydroxyheptadecan-2-yl]tetracos-15-enamide
N-tetracosanoyl-15-methylhexadecasphing-4-enine
An N-acyl-15-methylhexadecasphing-4-enine in which the acyl group has 24 carbons and 0 double bonds.
N-tetracosanoyl-14-methylhexadecasphingosine
A ceramide obtained by formal condensation of the carboxy group of tetracosanoic acid with the amino group of 14-methylhexadecasphingosine. It is a metabolite of the nematode Caenorhabditis elegans.
N-[(E)-1,3-dihydroxytetratriacont-4-en-2-yl]heptanamide
N-[(E)-1,3-dihydroxynon-4-en-2-yl]dotriacontanamide
N-[(E)-1,3-dihydroxytritriacont-4-en-2-yl]octanamide
N-[(E)-1,3-dihydroxyoctatriacont-4-en-2-yl]propanamide
(Z)-N-(1,3-dihydroxynonan-2-yl)dotriacont-21-enamide
N-[(E)-1,3-dihydroxydotriacont-4-en-2-yl]nonanamide
N-[(E)-1,3-dihydroxyhexatriacont-4-en-2-yl]pentanamide
N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tritriacontanamide
N-[(E)-1,3-dihydroxyheptatriacont-4-en-2-yl]butanamide
N-[(E)-1,3-dihydroxypentatriacont-4-en-2-yl]hexanamide
(Z)-N-(1,3-dihydroxyoctacosan-2-yl)tridec-9-enamide
N-[(E)-1,3-dihydroxyundec-4-en-2-yl]triacontanamide
N-[(E)-1,3-dihydroxyhentriacont-4-en-2-yl]decanamide
N-[(E)-1,3-dihydroxytridec-4-en-2-yl]octacosanamide
N-[(E)-1,3-dihydroxydec-4-en-2-yl]hentriacontanamide
(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tetracos-13-enamide
(Z)-N-(1,3-dihydroxyundecan-2-yl)triacont-19-enamide
N-[(E)-1,3-dihydroxydodec-4-en-2-yl]nonacosanamide
(Z)-N-(1,3-dihydroxyicosan-2-yl)henicos-11-enamide
N-[(E)-1,3-dihydroxytriacont-4-en-2-yl]undecanamide
(Z)-N-(1,3-dihydroxytricosan-2-yl)octadec-9-enamide
(Z)-N-(1,3-dihydroxytetracosan-2-yl)heptadec-9-enamide
(Z)-N-(1,3-dihydroxytridecan-2-yl)octacos-17-enamide
(Z)-N-(1,3-dihydroxypentacosan-2-yl)hexadec-9-enamide
(Z)-N-(1,3-dihydroxypentadecan-2-yl)hexacos-15-enamide
(Z)-N-(1,3-dihydroxynonadecan-2-yl)docos-13-enamide
N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]heptadecanamide
N-[(E)-1,3-dihydroxypentacos-4-en-2-yl]hexadecanamide
N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]docosanamide
N-[(E)-1,3-dihydroxytricos-4-en-2-yl]octadecanamide
N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]heptacosanamide
N-[(E)-1,3-dihydroxyhexacos-4-en-2-yl]pentadecanamide
N-[(E)-1,3-dihydroxydocos-4-en-2-yl]nonadecanamide
(Z)-N-(1,3-dihydroxyhexacosan-2-yl)pentadec-9-enamide
N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]hexacosanamide
(Z)-N-(1,3-dihydroxydocosan-2-yl)nonadec-9-enamide
N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]tetracosanamide
N-[(E)-1,3-dihydroxyheptacos-4-en-2-yl]tetradecanamide
N-[(E)-1,3-dihydroxynonacos-4-en-2-yl]dodecanamide
(Z)-N-(1,3-dihydroxyhenicosan-2-yl)icos-11-enamide
N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]pentacosanamide
N-[(E)-1,3-dihydroxyoctacos-4-en-2-yl]tridecanamide
(Z)-N-(1,3-dihydroxyheptacosan-2-yl)tetradec-9-enamide
(Z)-N-(1,3-dihydroxytetradecan-2-yl)heptacos-12-enamide
(Z)-N-(1,3-dihydroxyhexadecan-2-yl)pentacos-11-enamide
(Z)-N-(1,3-dihydroxynonacosan-2-yl)dodec-5-enamide
(Z)-N-(1,3-dihydroxytricosan-2-yl)octadec-11-enamide
(Z)-N-(1,3-dihydroxyoctadecan-2-yl)tricos-11-enamide
(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tetracos-11-enamide
(Z)-N-(1,3-dihydroxypentadecan-2-yl)hexacos-11-enamide
(Z)-N-(1,3-dihydroxypentacosan-2-yl)hexadec-7-enamide
(Z)-N-(1,3-dihydroxyoctacosan-2-yl)tridec-8-enamide
(Z)-N-(1,3-dihydroxynonadecan-2-yl)docos-11-enamide
N-[(E,2S,3R)-1,3-dihydroxyhenicos-8-en-2-yl]icosanamide
N-[(E,2S,3R)-1,3-dihydroxyoctadec-8-en-2-yl]tricosanamide
N-[(E,2S,3R)-1,3-dihydroxyheptadec-8-en-2-yl]tetracosanamide
(E)-N-[(2S,3R)-1,3-dihydroxyheptadecan-2-yl]tetracos-15-enamide
N-[(E,2S,3R)-1,3-dihydroxydocos-8-en-2-yl]nonadecanamide
N-[(E,2S,3R)-1,3-dihydroxypentadec-8-en-2-yl]hexacosanamide
N-[(E,2S,3R)-1,3-dihydroxyhexadec-8-en-2-yl]pentacosanamide
(E)-N-[(2S,3R)-1,3-dihydroxypentadecan-2-yl]hexacos-17-enamide
N-[(E,2S,3R)-1,3-dihydroxynonadec-8-en-2-yl]docosanamide
(E)-N-[(2S,3R)-1,3-dihydroxyhenicosan-2-yl]icos-11-enamide
(E)-N-[(2S,3R)-1,3-dihydroxynonadecan-2-yl]docos-13-enamide
N-[(E,2S,3R)-1,3-dihydroxyicos-8-en-2-yl]henicosanamide
N-tricosanoylsphingosine
A N-acylsphingosine in which the ceramide N-acyl group is specified as tricosanoyl.